Working… Menu

A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03947814
Recruitment Status : Terminated (Study 63623872FLZ1014 was terminated early based on a strategic business decision by Janssen to end the clinical development program of JNJ-63623872.)
First Posted : May 13, 2019
Last Update Posted : June 3, 2021
Information provided by (Responsible Party):
Janssen-Cilag International NV

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 9, 2020
Actual Study Completion Date : September 9, 2020